[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100200739":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":11,"locations":21,"responsibleParty":36,"collaborators":38,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":10,"eligibilityCriteria":48,"healthyVolunteers":44,"sex":49,"minAge":50,"maxAge":10,"enrollmentInfo":51,"targetDuration":10,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":10,"overallStatus":23,"whyStopped":10,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":66},{"fullName":5,"class":6},"Kurashiki Central Hospital","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"PCI for CTO",null,[12,18],{"name":13,"role":14,"phone":15,"phoneExt":16,"email":17},"Keiko Oka","CONTACT","81-86-422-0210","2742","cto.e.registry@gmail.com",{"name":19,"role":14,"phone":15,"phoneExt":10,"email":20},"Harumi Katoh, MD, PhD","hk10731@kchnet.or.jp",[22],{"facility":5,"status":23,"city":24,"state":10,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"RECRUITING","Kurashiki","710-8602","Japan","JP",{"type":29,"coordinates":30},"Point",[31,32],133.76667,34.58333,{"lat":32,"lon":31},[35],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":10},{"type":37,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[39],{"name":40,"class":41},"Japanese CTO PCI Expert Registry investigators","UNKNOWN","100200739","japanese-cto-pci-expert-registry-100200739",false,"NCT01889459","Japanese CTO PCI Expert Registry","Patient Registry of Percutaneous Coronary Intervention (PCI) for Chronic Total Occlusion (CTO) by Japanese Experts","Inclusion Criteria:\n\nPatients eligible for PCI\n\nPatients who underwent PCI for CTO lesions that contain the following:\n\n1. Thrombolysis in myocardial infarction trial (TIMI) 0\n2. The occlusive period more than 3 months or unknown\n3. The main coronary arteries (segment 1-3, 5-8, 11, 13), branches that have large perfusion area (segment 4PL, 9\u002F10, 12) and graft\n\nExclusion Criteria:\n\nPatients ineligible for PCI judged in clinical practice","ALL","20 Years",{"count":52,"type":53},19000,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to establish a consensus of treatment strategy of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) through patient registry of PCI for CTO performed by Japanese certified operators.",[57],"Chronic Total Occlusion of Coronary Artery","2013-07-01",{"date":60,"type":53},"2013-07-02",{"date":62,"type":10},"2013-07",{"date":64,"type":53},"2027-12",{"name":5,"class":6},1]